We also found that ANRIL could epigenetically repress Kruppel-like factor 2 (KLF2) transcription in HCC cells by binding with PRC2 and recruiting it to the KLF2 promoter region. This evidence concerns the gene CDKN2B-AS1 and hepatocellular carcinoma.